Detalhe da pesquisa
1.
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
Cell
; 184(16): 4203-4219.e32, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34242577
2.
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.
Nature
; 594(7864): 553-559, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33971664
3.
Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates.
Proc Natl Acad Sci U S A
; 118(23)2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34074774
4.
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.
Immunity
; 41(6): 909-18, 2014 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25526306
5.
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination.
Nature
; 543(7644): 248-251, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28151488
6.
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates.
J Virol
; 92(8)2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437967
7.
HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces gp41 Antibody Immunodominance in Rhesus Macaques.
J Virol
; 91(21)2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28794027
8.
HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.
J Immunol
; 197(12): 4663-4673, 2016 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27849170
9.
Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques.
J Virol
; 88(6): 3329-39, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24390332
10.
Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1.
J Virol
; 87(8): 4185-201, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23365441
11.
Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.
PLoS Pathog
; 7(9): e1002200, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21909262
12.
Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates.
bioRxiv
; 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187726
13.
Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine.
bioRxiv
; 2022 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35118474
14.
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine.
Nat Commun
; 13(1): 6309, 2022 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36274085
15.
SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeys.
bioRxiv
; 2021 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619494
16.
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates.
bioRxiv
; 2021 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33442694
17.
Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization.
Cell Rep
; 30(5): 1553-1569.e6, 2020 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32023469
18.
Immune checkpoint modulation enhances HIV-1 antibody induction.
Nat Commun
; 11(1): 948, 2020 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32075963
19.
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection.
J Virol
; 82(1): 115-25, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17942537
20.
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.
J Exp Med
; 215(6): 1571-1588, 2018 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29739835